 | • レポートコード：20QY06-05239 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、経口ワクチンのグローバル市場について種類別（ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他）、用途別（公衆、民間）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・経口ワクチン市場の概要 ・世界の主要地域別経口ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の経口ワクチン市場規模2015-2026：種類別（ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他） ・世界の経口ワクチン市場規模2015-2026：用途別（公衆、民間） ・経口ワクチンの北米市場規模2015-2020 ・経口ワクチンのヨーロッパ市場規模2015-2020 ・経口ワクチンの中国市場規模2015-2020 ・経口ワクチンの日本市場規模2015-2020 ・経口ワクチンの東南アジア市場規模2015-2020 ・経口ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck、GSK、Sanofi、Lanzhou Institute、Serum Institute、Valneva、Shanghai United Cell、Bibcol、PaxVax、Vabiotech、Tiantan Biological、EuBiologics、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals） ・経口ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・経口ワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Oral Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Oral Vaccines market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Oral Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Oral Vaccines industry.
Based on our recent survey, we have several different scenarios about the Oral Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2323.3 million in 2019. The market size of Oral Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Oral Vaccines market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Oral Vaccines market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Oral Vaccines market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Oral Vaccines market. The report also includes nautical information, where it shows Oral Vaccines market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Oral Vaccines market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Oral Vaccines market.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Geographical Analysis:
Based on region, the global Oral Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Oral Vaccines market are
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others
Segment by Application
Public
Private
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Oral Vaccines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Oral Vaccines market.
• The market share of the global Oral Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Oral Vaccines market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Oral Vaccines market.
1 Oral Vaccines Market Overview
1.1 Oral Vaccines Product Scope
1.2 Oral Vaccines Segment by Type
1.2.1 Global Oral Vaccines Sales by Type (2020-2026)
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.2.5 Others
1.3 Oral Vaccines Segment by Application
1.3.1 Global Oral Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Public
1.3.3 Private
1.4 Oral Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Oral Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Oral Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Oral Vaccines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Oral Vaccines Industry Impact
1.5.1 How the Covid-19 is Affecting the Oral Vaccines Industry
1.5.1.1 Oral Vaccines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Oral Vaccines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Oral Vaccines Players to Combat Covid-19 Impact
2 Oral Vaccines Estimate and Forecast by Region
2.1 Global Oral Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Oral Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Oral Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Oral Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Oral Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Oral Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Oral Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Oral Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Oral Vaccines Estimates and Projections (2015-2026)
2.4.3 China Oral Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Oral Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Oral Vaccines Estimates and Projections (2015-2026)
2.4.6 India Oral Vaccines Estimates and Projections (2015-2026)
3 Global Oral Vaccines Competition Landscape by Players
3.1 Global Top Oral Vaccines Players by Sales (2015-2020)
3.2 Global Top Oral Vaccines Players by Revenue (2015-2020)
3.3 Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Vaccines as of 2019)
3.4 Global Oral Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Oral Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Oral Vaccines Players (Opinion Leaders)
4 Global Oral Vaccines Market Size by Type
4.1 Global Oral Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Oral Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Oral Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Oral Vaccines Price by Type (2014-2020)
4.2 Global Oral Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Oral Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Oral Vaccines Price Forecast by Type (2021-2026)
5 Global Oral Vaccines Market Size by Application
5.1 Global Oral Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Oral Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Oral Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Oral Vaccines Price by Application (2015-2020)
5.2 Global Oral Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Oral Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Vaccines Price Forecast by Application (2021-2026)
3 North America Oral Vaccines Market Facts & Figures
3.2 North America Oral Vaccines Sales Market Share by Company (2015-2020)
3.3 North America Oral Vaccines Sales Market Share by Type (2015-2020)
3.4 North America Oral Vaccines Sales Market Share by Application (2015-2020)
4 Europe Oral Vaccines Market Facts & Figures
4.2 Europe Oral Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe Oral Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe Oral Vaccines Sales Market Share by Application (2015-2020)
5 China Oral Vaccines Market Facts & Figures
5.2 China Oral Vaccines Sales Market Share by Company (2015-2020)
5.3 China Oral Vaccines Sales Market Share by Type (2015-2020)
5.4 China Oral Vaccines Sales Market Share by Application (2015-2020)
6 Japan Oral Vaccines Market Facts & Figures
6.2 Japan Oral Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan Oral Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan Oral Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia Oral Vaccines Market Facts & Figures
7.2 Southeast Asia Oral Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Oral Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Oral Vaccines Sales Market Share by Application (2015-2020)
8 India Oral Vaccines Market Facts & Figures
8.2 India Oral Vaccines Sales Market Share by Company (2015-2020)
8.3 India Oral Vaccines Sales Market Share by Type (2015-2020)
8.4 India Oral Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Oral Vaccines Business
12.1 Merck
12.1.1 Merck Oral Vaccines Corporation Information
12.1.2 Merck Oral Vaccines Business Overview and Total Revenue
12.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Oral Vaccines Products Offered
12.1.5 Merck Recent Development
12.2 GSK
12.2.1 GSK Oral Vaccines Corporation Information
12.2.2 GSK Oral Vaccines Business Overview and Total Revenue
12.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Oral Vaccines Products Offered
12.2.5 GSK Recent Development
12.3 Sanofi
12.3.1 Sanofi Oral Vaccines Corporation Information
12.3.2 Sanofi Oral Vaccines Business Overview and Total Revenue
12.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Oral Vaccines Products Offered
12.3.5 Sanofi Recent Development
12.4 Lanzhou Institute
12.4.1 Lanzhou Institute Oral Vaccines Corporation Information
12.4.2 Lanzhou Institute Oral Vaccines Business Overview and Total Revenue
12.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Lanzhou Institute Oral Vaccines Products Offered
12.4.5 Lanzhou Institute Recent Development
12.5 Serum Institute
12.5.1 Serum Institute Oral Vaccines Corporation Information
12.5.2 Serum Institute Oral Vaccines Business Overview and Total Revenue
12.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Serum Institute Oral Vaccines Products Offered
12.5.5 Serum Institute Recent Development
12.6 Valneva
12.6.1 Valneva Oral Vaccines Corporation Information
12.6.2 Valneva Oral Vaccines Business Overview and Total Revenue
12.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Valneva Oral Vaccines Products Offered
12.6.5 Valneva Recent Development
12.7 Shanghai United Cell
12.7.1 Shanghai United Cell Oral Vaccines Corporation Information
12.7.2 Shanghai United Cell Oral Vaccines Business Overview and Total Revenue
12.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Shanghai United Cell Oral Vaccines Products Offered
12.7.5 Shanghai United Cell Recent Development
12.8 Bibcol
12.8.1 Bibcol Oral Vaccines Corporation Information
12.8.2 Bibcol Oral Vaccines Business Overview and Total Revenue
12.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bibcol Oral Vaccines Products Offered
12.8.5 Bibcol Recent Development
12.9 PaxVax
12.9.1 PaxVax Oral Vaccines Corporation Information
12.9.2 PaxVax Oral Vaccines Business Overview and Total Revenue
12.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 PaxVax Oral Vaccines Products Offered
12.9.5 PaxVax Recent Development
12.10 Vabiotech
12.10.1 Vabiotech Oral Vaccines Corporation Information
12.10.2 Vabiotech Oral Vaccines Business Overview and Total Revenue
12.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Vabiotech Oral Vaccines Products Offered
12.10.5 Vabiotech Recent Development
12.11 Tiantan Biological
12.11.1 Tiantan Biological Oral Vaccines Corporation Information
12.11.2 Tiantan Biological Oral Vaccines Business Overview and Total Revenue
12.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Tiantan Biological Oral Vaccines Products Offered
12.11.5 Tiantan Biological Recent Development
12.12 EuBiologics
12.12.1 EuBiologics Oral Vaccines Corporation Information
12.12.2 EuBiologics Oral Vaccines Business Overview and Total Revenue
12.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.12.4 EuBiologics Oral Vaccines Products Offered
12.12.5 EuBiologics Recent Development
12.13 Panacea Biotec Ltd
12.13.1 Panacea Biotec Ltd Oral Vaccines Corporation Information
12.13.2 Panacea Biotec Ltd Oral Vaccines Business Overview and Total Revenue
12.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Panacea Biotec Ltd Oral Vaccines Products Offered
12.13.5 Panacea Biotec Ltd Recent Development
12.14 Bio-Med
12.14.1 Bio-Med Oral Vaccines Corporation Information
12.14.2 Bio-Med Oral Vaccines Business Overview and Total Revenue
12.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Bio-Med Oral Vaccines Products Offered
12.14.5 Bio-Med Recent Development
12.15 Halfkin Bio-Pharmaceuticals
12.15.1 Halfkin Bio-Pharmaceuticals Oral Vaccines Corporation Information
12.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Business Overview and Total Revenue
12.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Products Offered
12.15.5 Halfkin Bio-Pharmaceuticals Recent Development
13 Oral Vaccines Manufacturing Cost Analysis
13.1 Oral Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oral Vaccines
13.4 Oral Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oral Vaccines Distributors List
14.3 Oral Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Oral Vaccines Sales (M Doses) Growth Rate by Type (2020-2026)
Table 2. Global Oral Vaccines Sales (M Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Oral Vaccines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Oral Vaccines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Oral Vaccines Players to Combat Covid-19 Impact
Table 8. Global Market Oral Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Oral Vaccines Sales (M Doses) by Region (2015-2020)
Table 10. Global Oral Vaccines Sales Market Share by Region (2015-2020)
Table 11. Global Oral Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Oral Vaccines Revenue Share by Region (2015-2020)
Table 13. Global Oral Vaccines Sales (M Doses) Forecast by Region (2021-2026)
Table 14. Global Oral Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Oral Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Oral Vaccines Revenue Share Forecast by Region (2021-2026)
Table 17. Global Oral Vaccines (M Doses) of Key Companies (2015-2020)
Table 18. Global Oral Vaccines Sales Share by Company (2015-2020)
Table 19. Global Oral Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Oral Vaccines Revenue Share by Company (2015-2020)
Table 21. Global Oral Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Vaccines as of 2019)
Table 22. Global Oral Vaccines Average Price (USD/K Doses) of Key Company (2015-2020)
Table 23. Manufacturers Oral Vaccines Manufacturing Sites and Area Served
Table 24. Manufacturers Oral Vaccines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Oral Vaccines Players
Table 27. Global Oral Vaccines Sales (M Doses) by Type (2015-2020)
Table 28. Global Oral Vaccines Sales Share by Type (2015-2020)
Table 29. Global Oral Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Oral Vaccines Price (M Doses) by Type (2015-2020)
Table 31. Global Oral Vaccines Sales Share by Type (2021-2026)
Table 32. Global Oral Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Oral Vaccines Revenue Share by Type (2021-2026)
Table 34. Global Oral Vaccines Price (M Doses) by Type (2021-2026)
Table 35. Global Oral Vaccines Sales (M Doses) by Application (2015-2020)
Table 36. Global Oral Vaccines Sales Share by Application (2015-2020)
Table 37. Global Oral Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Oral Vaccines Price (M Doses) by Application (2015-2020)
Table 39. Global Oral Vaccines Sales (M Doses) by Application (2021-2026)
Table 40. Global Oral Vaccines Sales Share by Application (2021-2026)
Table 41. Global Oral Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Oral Vaccines Revenue Share by Application (2021-2026)
Table 43. Global Oral Vaccines Price (M Doses) by Application (2021-2026)
Table 44. United States Oral Vaccines Sales (M Doses) by Company (2015-2020)
Table 45. United States Oral Vaccines Sales Market Share by Company (2015-2020)
Table 46. United States Oral Vaccines Sales (M Doses) by Type (2015-2020)
Table 47. United States Oral Vaccines Sales Market Share by Type (2015-2020)
Table 48. United States Oral Vaccines Sales (M Doses) by Application (2015-2020)
Table 49. United States Oral Vaccines Sales Market Share by Application (2015-2020)
Table 50. Europe Oral Vaccines Sales (M Doses) by Company (2015-2020)
Table 51. Europe Oral Vaccines Sales Market Share by Company (2015-2020)
Table 52. Europe Oral Vaccines Sales (M Doses) by Type (2015-2020)
Table 53. Europe Oral Vaccines Sales Market Share by Type (2015-2020)
Table 54. Europe Oral Vaccines Sales (M Doses) by Application (2015-2020)
Table 55. Europe Oral Vaccines Sales Market Share by Type (2015-2020)
Table 56. China Oral Vaccines Sales (M Doses) by Company (2015-2020)
Table 57. China Oral Vaccines Sales Market Share by Company (2015-2020)
Table 58. China Oral Vaccines Sales (M Doses) by Type (2015-2020)
Table 59. China Oral Vaccines Sales Market Share by Type (2015-2020)
Table 60. China Oral Vaccines Sales (M Doses) by Application (2015-2020)
Table 61. China Oral Vaccines Sales Market Share by Application (2015-2020)
Table 62. Japan Oral Vaccines Sales (M Doses) by Company (2015-2020)
Table 63. Japan Oral Vaccines Sales Market Share by Company (2015-2020)
Table 64. Japan Oral Vaccines Sales (M Doses) by Type (2015-2020)
Table 65. Japan Oral Vaccines Sales Market Share by Type (2015-2020)
Table 66. Japan Oral Vaccines Sales (M Doses) by Application (2015-2020)
Table 67. Japan Oral Vaccines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Oral Vaccines Sales (M Doses) by Company (2015-2020)
Table 69. Southeast Asia Oral Vaccines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Oral Vaccines Sales (M Doses) by Type (2015-2020)
Table 71. Southeast Asia Oral Vaccines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Oral Vaccines Sales (M Doses) by Type (2015-2020)
Table 73. Southeast Asia Oral Vaccines Sales Market Share by Application (2015-2020)
Table 74. India Oral Vaccines Sales (M Doses) by Company (2015-2020)
Table 75. India Oral Vaccines Sales Market Share by Company (2015-2020)
Table 76. India Oral Vaccines Sales (M Doses) by Type (2015-2020)
Table 77. India Oral Vaccines Sales Market Share by Type (2015-2020)
Table 78. India Oral Vaccines Sales (M Doses) by Application (2015-2020)
Table 79. India Oral Vaccines Sales Market Share by Application (2015-2020)
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 83. Merck Oral Vaccines Product
Table 84. Merck Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 88. GSK Oral Vaccines Product
Table 89. GSK Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 93. Sanofi Oral Vaccines Product
Table 94. Sanofi Recent Development
Table 95. Lanzhou Institute Corporation Information
Table 96. Lanzhou Institute Description and Business Overview
Table 97. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 98. Lanzhou Institute Oral Vaccines Product
Table 99. Lanzhou Institute Recent Development
Table 100. Serum Institute Corporation Information
Table 101. Serum Institute Description and Business Overview
Table 102. Serum Institute Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 103. Serum Institute Oral Vaccines Product
Table 104. Serum Institute Recent Development
Table 105. Valneva Corporation Information
Table 106. Valneva Description and Business Overview
Table 107. Valneva Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 108. Valneva Oral Vaccines Product
Table 109. Valneva Recent Development
Table 110. Shanghai United Cell Corporation Information
Table 111. Shanghai United Cell Description and Business Overview
Table 112. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 113. Shanghai United Cell Oral Vaccines Product
Table 114. Shanghai United Cell Recent Development
Table 115. Bibcol Corporation Information
Table 116. Bibcol Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 117. Bibcol Description and Business Overview
Table 118. Bibcol Oral Vaccines Product
Table 119. Bibcol Recent Development
Table 120. PaxVax Corporation Information
Table 121. PaxVax Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 122. PaxVax Description and Business Overview
Table 123. PaxVax Oral Vaccines Product
Table 124. PaxVax Recent Development
Table 125. Vabiotech Corporation Information
Table 126. Vabiotech Description and Business Overview
Table 127. Vabiotech Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 128. Vabiotech Oral Vaccines Product
Table 129. Vabiotech Recent Development
Table 130. Tiantan Biological Corporation Information
Table 131. Tiantan Biological Description and Business Overview
Table 132. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 133. Tiantan Biological Oral Vaccines Product
Table 134. Tiantan Biological Recent Development
Table 135. EuBiologics Corporation Information
Table 136. EuBiologics Description and Business Overview
Table 137. EuBiologics Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 138. EuBiologics Oral Vaccines Product
Table 139. EuBiologics Recent Development
Table 140. Panacea Biotec Ltd Corporation Information
Table 141. Panacea Biotec Ltd Description and Business Overview
Table 142. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 143. Panacea Biotec Ltd Oral Vaccines Product
Table 144. Panacea Biotec Ltd Recent Development
Table 145. Bio-Med Corporation Information
Table 146. Bio-Med Description and Business Overview
Table 147. Bio-Med Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 148. Bio-Med Oral Vaccines Product
Table 149. Bio-Med Recent Development
Table . Halfkin Bio-Pharmaceuticals Corporation Information
Table . Halfkin Bio-Pharmaceuticals Description and Business Overview
Table . Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table . Halfkin Bio-Pharmaceuticals Oral Vaccines Product
Table . Halfkin Bio-Pharmaceuticals Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Oral Vaccines Distributors List
Table 158. Oral Vaccines Customers List
Table 159. Market Key Trends
Table 160. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 161. Key Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Vaccines Product Picture
Figure 2. Global Oral Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Oral Vaccines Market Share by Application in 2020 & 2026
Figure 6. Public Examples
Figure 7. Private Examples
Figure 8. Global Oral Vaccines Sales (M Doses) Growth Rate (2015-2026)
Figure 9. Global Oral Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Oral Vaccines Price Trends Growth Rate (2015-2026) (USD/K Doses)
Figure 11. Global Oral Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Oral Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Oral Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Oral Vaccines Sales (M Doses) Growth Rate (2015-2026)
Figure 15. Europe Oral Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Oral Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Oral Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Oral Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Oral Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Oral Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Oral Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Oral Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Oral Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Oral Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Oral Vaccines Players Market Share by Revenue in Oral Vaccines 2015 & 2019
Figure 26. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Oral Vaccines Revenue Share by Type (2015-2020)
Figure 28. Global Oral Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Oral Vaccines Revenue Share by Application (2015-2020)
Figure 30. Global Oral Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Oral Vaccines Sales Market Share by Type in 2019
Figure 32. United States Oral Vaccines Sales Market Share by Type in 2019
Figure 33. Europe Oral Vaccines Sales Market Share by Company in 2019
Figure 34. Europe Oral Vaccines Sales Market Share by Type in 2019
Figure 35. Europe Oral Vaccines Sales Market Share by Application in 2019
Figure 36. China Oral Vaccines Sales Market Share by Company in 2019
Figure 37. China Oral Vaccines Sales Market Share by Type in 2019
Figure 38. China Oral Vaccines Sales Market Share by Application in 2019
Figure 39. Japan Oral Vaccines Sales Market Share by Company in 2019
Figure 40. Japan Oral Vaccines Sales Market Share by Type in 2019
Figure 41. Japan Oral Vaccines Sales Market Share by Application in 2019
Figure 42. Southeast Asia Oral Vaccines Sales Market Share by Company in 2019
Figure 43. Southeast Asia Oral Vaccines Sales Market Share by Type in 2019
Figure 44. Southeast Asia Oral Vaccines Sales Market Share by Application in 2019
Figure 45. India Oral Vaccines Sales Market Share by Company in 2019
Figure 46. India Oral Vaccines Sales Market Share by Type in 2019
Figure 47. India Oral Vaccines Sales Market Share by Application in 2019
Figure 48. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Lanzhou Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Serum Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Valneva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Shanghai United Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bibcol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. PaxVax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Vabiotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Tiantan Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. EuBiologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Panacea Biotec Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Bio-Med Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Halfkin Bio-Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Key Raw Materials Price Trend
Figure 64. Manufacturing Cost Structure of Oral Vaccines
Figure 65. Manufacturing Process Analysis of Oral Vaccines
Figure 66. Oral Vaccines Industrial Chain Analysis
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. Porter's Five Forces Analysis
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
経口ロタウイルスワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Rotavirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Rotavirus Vaccine…- 単純ヘルペスウイルス（HSV）ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Herpes Simplex Virus (HSV) Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically …
- H7N9ワクチンの世界市場レポート2020 Market Analysis and Insights: Global H7N9 Vaccines Market The global H7N9 Vaccines market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global H7N9 Vaccines Scope and Market Size The global H7N9 Vaccines market is se…
- HPV治療ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global HPV Therapeutic Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HPV Therapeutic Vacc…
- mRNAワクチンおよび治療薬の世界市場レポート2020 mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically wh…